Efficacy and safety of CalliSpheres® microspheres drug-eluting beads transarterial chemoembolization in GCLM combined trans-arterial infusion therapy for treating primary focus of gastric cancer: a multi-center retrospective study

References

• Kerkar SP, Kemp CD, Avital I. Liver resections in metastatic gastric cancer. HPB (Oxford). 2010 Nov;12(9):589–596. doi: 10.1111/j.1477-2574.2010.00224.x
   PubMed Web of Science ®Google Scholar
• Riihimäki M, Hemminki A, Sundquist K, et al. Metastatic spread in patients with gastric cancer, et al. Oncotarget. 2016 Aug 9;7(32):52307–52316. doi: 10.18632/oncotarget.10740
   PubMedGoogle Scholar
• Wang WJ, Liang H, Zhang H, et al. Prognostic significance of radical surgical treatment for gastric cancer patients with synchronous liver metastases. Med Oncol. 2014 Nov;31(11):258. doi: 10.1007/s12032-014-0258-3
   PubMed Web of Science ®Google Scholar
• Ricci AD, Rizzo A, Llimpe FLR, et al. Novel HER2-directed treatments in advanced gastric carcinoma: AnotHER paradigm shift? Cancers (Basel). 2021 Apr 1;13(7):1664. doi: 10.3390/cancers13071664
   PubMed Web of Science ®Google Scholar
• Viscardi G, Tralongo AC, Massari F, et al. Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis.Eur. J Cancer. 2022 Dec;177:175–185. doi: 10.1016/j.ejca.2022.09.031
   Web of Science ®Google Scholar
• Xiao YB, Zhang B, Wu YL. Prognostic analysis and liver metastases relevant factors after gastric and hepatic surgical treatment in gastric cancer patients with metachronous liver metastases: a population-based study. Ir J Med Sci. 2019;188(2):415–424. doi: 10.1007/s11845-018-1864-4
   PubMed Web of Science ®Google Scholar
• Zhao GS, Liu S, Chen SB, et al. Assessment of efficacy and safety by CalliSpheres versus HepaSpheres for drug-eluting bead transarterial chemoembolization in unresectable large hepatocellular carcinoma patients. Drug Deliv. 2021 Dec;28(1):1356–1362.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhou J, Zhu DD, et al. CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study. Clin Transl Oncol. 2019;21(2):167–177. doi: 10.1007/s12094-018-1902-8
   PubMed Web of Science ®Google Scholar
• Zhao GS, Liu S, Liu Y, et al. Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study. World J Surg Onc. 2021;19(1):249. doi: 10.1186/s12957-021-02332-0
   PubMed Web of Science ®Google Scholar
• Xu H, Min XL, Ren YJ, et al. Comparative study of drug-eluting beads versus conventional transarterial chemoembolization for treating peculiar anatomical sites of gastric cancer liver metastasis. Med Sci Monit. 2020 May 31;26:e922988. doi: 10.12659/MSM.922988
   PubMed Web of Science ®Google Scholar
• Zhao GS, Liu S, Zhang YW, et al. Irinotecan eluting beads-transarterial chemoembolization using Callispheres® microspheres is an effective and safe approach in treating unresectable colorectal cancer liver metastases. Ir J Med Sci. 2021, Jul 15;191(3):1139–1145. doi: 10.1007/s11845-021-02629-9
   PubMed Web of Science ®Google Scholar
• Li Z, Fan B, Shan F, et al. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospective comparative study. World J Surg Oncol. 2015 Jul 1;13(1):212. doi: 10.1186/s12957-015-0627-1
   PubMedGoogle Scholar
• Chen L, Song MQ, Lin HZ, et al. Chemotherapy and resection for gastric cancer with synchronous liver metastases. World J Gastroenterol. 2013 Apr 7;19(13):2097. doi: 10.3748/wjg.v19.i13.2097
   PubMed Web of Science ®Google Scholar
• Rizzo A, Mollica V, Ricci AD, et al. Third- and later-line treatment in advanced or metastatic gastric cancer: a systematic review and meta-analysis. Future Oncol. 2020 Jan;16(2):4409–4418.
   PubMed Web of Science ®Google Scholar
• Guo Y, Tang J, Huang XE, et al. Efficacy and toxicity of apatinib combined with or without chemotherapy for patients with advanced or metastatic chemotherapy-refractory gastric adenocarcinoma: A prospective clinical study. Medicine. 2019 Feb;98(6):e13908. doi: 10.1097/MD.0000000000013908
   PubMed Web of Science ®Google Scholar
• Li J, Qin SK, Xu JM, et al. RandomIzed, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction. J Clin Oncol. 2016 1;34(13):1448–1454. doi: 10.1200/JCO.2015.63.5995
   PubMed Web of Science ®Google Scholar
• Zou K, Yang SL, Zheng L, et al. Efficacy and safety of target combined chemotherapy in advanced gastric cancer: a meta-analysis and system review. BMC Cancer. 2016 15;16(1):737. doi: 10.1186/s12885-016-2772-5
   PubMedGoogle Scholar
• Chen L, Shi H, Che Y, et al. Efficacy of endostatin combined with continuous transcatheter arterial infusion and chemoembolization on gastric cancer with liver metastasis and analysis of prognosis. J Buon. 2020;25(3):1469–1475.
   PubMed Web of Science ®Google Scholar
• Wang TX, Dong JH, Zhang YW, et al. Efficacy and safety of hepatic artery infusion chemotherapy with mFOLFOX in primary liver cancer patients with hyperbilirubinemia and ineffective drainage: a retrospective cohort study. Ann Transl Med. 2022;10(7):411. doi: 10.21037/atm-22-978
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Hou SH, Yu JZ, et al. Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis. Front Oncol. 2023;12:1086095. doi: 10.3389/fonc.2022.1086095
   PubMed Web of Science ®Google Scholar
• Liu S, Yu GG, Wang QD, et al. CalliSpheres® microspheres drug-eluting bead transhepatic artery chemoembolization with or without sorafenib for the treatment of large liver cancer: a multi-center retrospective study. Am J Transl Res. 2021;13(12):13931–13940.
   PubMed Web of Science ®Google Scholar
• Ren ZZ, Yue YX, Zhang YW, et al. Changes in the peripheral blood treg cell proportion in hepatocellular carcinoma patients after transarterial chemoembolization with microparticles. Front Immunol. 2021;12:624789. doi: 10.3389/fimmu.2021.624789
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu S, Zhao GS, et al. Early changes in peripheral blood cytokine levels after the treatment of metastatic hepatic carcinoma with CalliSpheres microspheres drug-eluting beads transcatheter arterial chemoembolization. Front Oncol. 2022;12:889312. doi: 10.3389/fonc.2022.889312
   PubMed Web of Science ®Google Scholar
• Rihawi K, Ricci AD, Rizzo A, et al. Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications. Int J Mol Sci. 2021;22(8):3805. doi: 10.3390/ijms22083805
   PubMed Web of Science ®Google Scholar